Latest Addus Homecare Corp (ADUS) Headlines Addus

New Post Public Reply Private Reply Replies (0) Message Board

Mar 12, 2014 at 5:30 PM

Latest Addus Homecare Corp (ADUS) Headlines

Addus HomeCare Reports Fourth Quarter 2013 Results
PR Newswire - 1 hr 30 mins ago
Addus HomeCare Corporation (Nasdaq: ADUS), a comprehensive provider of home and community based services, which are primarily social in nature and provided in the home, and focused on the dual eligible population, announced today its financial results for the fourth quarter and year ended December 31, 2013.

5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 11, 11:27AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Addus HomeCare Announces Fourth Quarter 2013 Earnings Release and Conference Call
PR Newswire - Tue Feb 25, 11:30AM CST
Addus HomeCare Corporation (Nasdaq: ADUS), a comprehensive provider of home and community based services focused primarily on the dual eligible population, announced today that it will release earnings for the fourth quarter ended December 31, 2013 on Wednesday, March 12, 2014 after the market closes.

Saddle Creek Takes CNG Cross-Country
PR Newswire - Thu Feb 13, 3:30PM CST
(MindShare Strategies Media Services) This weekend, Saddle Creek Logistics Services will embark on "The Great American Green Ride," the first cross-country trip with a for-hire, compressed natural gas (CNG) truck.

DaVita Healthcare Beats on Q4 Earnings & Revs, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 10:20AM CST
DaVita HealthCare reported fourth-quarter 2013 net operating earnings of 99 cents per share, beating the Zacks Consensus Estimate by a penny

Quest Diagnostics Raised to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 2:10PM CST
On Feb 7, we upgraded Quest Diagnostics to Neutral following a decent fourth-quarter 2013.

CVS Caremark Beats on Q4 Earnings & Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 1:24PM CST
CVS Caremark reported third-quarter 2013 adjusted EPS of $1.12.

Weakness Seen in Prestige Brands Holdings (PBH): Stock Tumbles 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 7:38AM CST
The shares of Prestige Brands Holdings, Inc fell over 9% on the day.This continues the most recent downtrend for PBH, as the stock is down over 24% in the last one month.This medical equipment provider has seen a flat track record when it comes to current year estimate revisions.

HCA Holdings Beats on Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 12:20PM CST
HCA Holdings reported fourth-quarter 2013 operating net income of 92 cents per share which surpassed the Zacks Consensus Estimate of by nearly 7%.

Zacks Rank #1 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (strong buy) List for Monday

RadNet (RDNT) in Focus: Stock Adds 10.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 24, 8:39AM CST
RadNet, Inc. was a big mover last session, as its shares rose over 10% on the day.

Tenet Upped to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 1:30PM CST
On Jan 22, 2014 we upgraded our recommendation on Tenet Healthcare Corp. to Neutral

Zacks #1 Rank Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 23, 8:30AM CST
Here are 5 stocks added to the Zacks #5 Rank ("strong buy") List for Thursday

Tenet Downgraded to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 1:10PM CST
Zacks Investment Research downgraded Tenet Healthcare Corp. to a Zacks Rank #4 (Sell) on Jan 21, 2014.

WellCare Health Slips to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 12:50PM CST
Zacks Investment Research downgraded WellCare Health Plans, Inc. to a Zacks Rank #4 (Sell) on Jan 18, 2014.

HCA Holdings' 2013 Prelim Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 4:31PM CST
HCA Holdings anticipates adjusted EBITDA for 2013 to be about $7.15-7.25 billion, $65 to $75 million above the high-end of its previous guidance of $6.25 to $6.50 billion.

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 15, 8:30AM CST
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Wednesday

IlliniCare Health Plan, Addus Examine Home Care's Role in Managed Long Term Care
PR Newswire - Mon Jan 13, 11:00AM CST
One of the nation's first studies examining the effect real-time tracking of health status can have on health outcomes has begun within the context of Illinois' Integrated Care Program (ICP). IlliniCare Health Plan, a subsidiary of Centene Corp. (NYSE: CNC), and Addus HomeCare Corporation (NASDAQ: ADUS), a national provider of Home and Community-Based Services (HCBS), announced today they have initiated a study to assess the impact of equipping home care workers with mobile devices, enabling real-time reporting of change in consumer condition.

Almost Family (AFAM) Soars: Stock Up 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 8:39AM CST
Almost Family Inc. was a big mover last session, as its shares rose almost 8% on the day.

Addus HomeCare Inc. (ADUS) Stock Research Links

ADUS Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...